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Available online ▪ ▪ ▪AbstractPurpose: To evaluate the efficacy of botulinum toxin injection in the patients with type 1 Duane syndrome and identify the predictive factors for
success.
Methods: Sixteen patients with esotropic type 1 Duane syndrome without history of ocular surgery were selected for this interventional case
series. The botulinum toxin was injected in the medial rectus of all patients. Visual acuity, dry refraction, cyclo-refraction, ocular motility, and
amount of deviation were measured. Complete success, partial success, and failure were defined as residual deviation/face turn less than 8 prism
diopters (PD)/5, 8-20 PD/5-15, and equal or greater than 20 PD/15, respectively.
Results: Sixteen cases (6 males) were included in our study. The mean esotropia was 26.27 ± 8.35 (12-40 PD) which reduced significantly to
13.5 ± 12.39PD esotropia during 6 months follow-up (p < 0.001). Face turn was improved significantly from a preoperative mean of 18.27 to:
0.094 at 1 week, 0.11 at 1 month, 3.31 at 3 months, and 7 at 6 months (p < 0.001). Complete success was seen in 6 patients (37.5%), partial
success in 4 patients (25%), and failure in 6 patients (37.5%). There was a significant relation between the amount of forced duction testing and
the success rate (p: 0.019). No complication was seen during injections.
Conclusions: Botulinum toxin could be an alternative treatment in Duane syndrome with appropriate case selection. Forced duction testing could
be a predictive factor for response to botulinum toxin.
Copyright © 2016, Iranian Society of Ophthalmology. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Duane syndrome is a congenital disorder with ocular
motility impairment associated with disorder of innervation.1
The misinnervations convert ocular motility from a normal
pattern to the limited movement with globe retraction and
narrowing palpebral fissure.1 Duane syndrome shows differentThis manuscript data has been applied with taking informed consent from
patients.
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movements to cases with anomalous head posture and sig-
nificant deviation in primary position. It may be unilateral or
bilateral. In bilateral cases, different types of Duane syndrome
may be seen in each eye. Horizontal rectus muscle recession is
recognized as the main treatment of this disorder.2 Surgical
indications included deviation in primary position, anomalous
head posture, marked globe retraction, and large upshoot and
downshoot.3 The treatment corrects the deviation and anom-
alous head posture without significant improvement of
movement limitations.4 The surgical goals may be obtained by
nonsurgical techniques. Botulinum toxin injection into rectus
muscles may be an appropriate management in some of the
patients with Duane syndrome.5e7 This study was performed
for evaluation of the efficacy of botulinum toxin injection inhe patients with Duane syndrome type 1, Journal of Current Ophthalmology
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Table 2
Relation between forced duction test and success rate.
Success
Complete Partial Failed
FDT þ1 Count 1 1
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+ MODELpatients with type 1 Duane syndrome and to identify the
predictive factors for success.
Methods
This interventional case series was performed in Farabi Eye
Hospital from February 2009 to November 2009. Institutional
Review Board approval was gained, and the tenets of the
Declaration of Helsinki were followed. Patients with type 1
Duane syndrome associated with significant eso-deviation (at
least 12 prism diopters (PD)) in primary position entered the
study. Other types of Duane syndrome and history of ocular
surgery were considered as exclusion criteria of our study.
Informed consent was obtained from all patients or their
parents. Pre-injection examinations included: uncorrected and
best corrected visual acuity (UCVA and BCVA), dry refrac-
tion, cyclo-refraction, complete slit-lamp examination, ocular
motility, and amount of deviation and abnormal face turn. The
measurement of deviation and face turn were performed by
alternate prism cover test and goniometer, respectively (all
were measured by one ophthalmologist [A.A.]). Follow-up
visits were done pre-operatively and 1 day, 1 week, 1
month, 3 months, and 6 months after the procedure. The pa-
tients were categorized into three groups: complete success
(residual deviation less than 8 PD and residual face turn under
5), partial success (residual deviation between 8 and 20 PD
and residual face turn between 5e15), and failure (no sig-
nificant improvement in deviation and face turn, residual
deviation20 PD and residual face turn15).
Method of procedure: The procedure was performed
without Electromyography (EMG) guide8 and under general
or local anesthesia. All procedures were done by one surgeon
(A.A.). Phenylephrine 2.5% eye drops were utilized twice with
5-min intervals to facilitate muscle findings and carry out
fundoscopy after injection to evaluate possible retinal injury.
Then forced duction testing (FDT) in horizontal plane was
done, and FDT was graded (Table 1). In the next step, the
3.5 IU of Novotox Ultra™ (35 u/vial, DPS company, China
and distributed by donaexperts Inc, Montreal, Canada) was
injected by needle with a 27-gauge needle. After taking out the
needle, an applicator was placed on it for 30 s. The patients
were placed in a semi-sitting position after the injection. Af-
terward, in suspected cases of sclera penetration, fundoscopy
was performed.Table 1
Grading of forced duction testing.
Grading Definition
1þ 1 It was not normal, and
2 It passed from the midline, and
3 The light reflex was not seen on the cornea.
2þ 1 It passed from the midline, but
2 The light reflex was seen on the cornea.
3þ 1 It reached the midline, but
2 Did not pass from this line
(approximately the light reflex was matched
with the center of cornea).
4þ Did not reach the midline.
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version 14 (SPSS Inc, Chicago, USA). The quantitative data
were shown as mean ± SD. The data were compared by paired
t test. The difference of success rate based on the grading of
FDT, gender, and age was analyzed by Chi square test and
ANOVA test, respectively. p < 0.05 was considered statisti-
cally significant.
Results
The patients included 6 males and 10 females with the age
range of 1e21 years. Duane syndrome involved the left eye in
11 cases (68.75%), the right eye in 3 cases (18.75%), and both
eyes in 2 cases (12.5%). There were 11 patients (68.75%) with
amblyopia with the distribution of mild (BCVA 20/25-20/40),
moderate (BCVA 20/40-20/100), and severe (BCVA worse
than 20/100) in 4, 6, and 1 patients, respectively.
All of our patients had esotropia and face turn in the di-
rection of Duane's eye. The mean esotropia was 26.27 ± 8.35
PD (12-40 PD) which reduced significantly to a mean of
5.5 ± 13.01 PD exotropia at 1 week, 2.55 ± 12.00 PD exo-
tropia at 1 month, 5.43 ± 11.74PD esotropia at 3 months, and
13.5 ± 12.39 PD esotropia at 6 months after the procedure
(p < 0.001 in all follow-up visits). Face turn was improved
significantly from a preoperative mean of 18.27 ± 7.29 to:
0.094 ± 2.99 at 1 week, 0.11 ± 3.54 at 1 month,
3.31 ± 5.10 at 3 months, and 7 ± 10.19 at 6 months
(p < 0.001). The face turn was completely corrected in 2
patients after Botulinum toxin injection and remained stable
up to 6 months follow-up.
Complete success was seen in 6 patients (37.5%), partial
success in 4 patients (25%), and failure in 6 patients (37.5%).
There was significant direct relation between the amount of
FDT and success rate (p: 0.019) (Table 2). There was no sig-
nificant relation between success rate and age or sex (p: 0.378
and 0.169, respectively). Table 3 shows mean primary devia-
tion and face turn in 3 success category groups.% within FDT 50 50
% within success 16.7 25
þ2 Count 5 1
% within FDT 83.3 16.7
% within success 83.3 25
þ3 Count 2 3
% within FDT 40 60
% within success 50 50
þ4 Count 3
% within FDT 100
% within success 50
Total Count 6 4 6
% within FDT 37.5 25 37.5
% within success 100 100 100
FDT: Forced duction test.
he patients with Duane syndrome type 1, Journal of Current Ophthalmology
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Esodeviation 26.27 ± 8.35 18 ± 4.42 33.75 ± 4.78 30.83 ± 5.24
Face turn 18.27 ± 7.29 13.67 ± 3.50 22 ± 6.50 21.17 ± 8.94
PD: prism diopter.
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seen during the procedure. Subconjunctival hemorrhage (5
patients), ptosis (mild in 5 patients, moderate in 3 patients),
and vertical strabismus (3 patients) were transient complica-
tions after the injections.
Discussion
Duane syndrome is one of the congenital disorders with
impaired cranial nerve innervations to the ocular rectus mus-
cles. The deviation in this syndrome is usually treated by
muscle recession in affected side or both eyes based on
amount of deviation.6,9 A low rate of amblyopia has been
reported in Duane syndrome.10 In contrast, our patients
showed a 68.75% rate of amblyopia. This high rate may be
explained by the referral nature of our hospital. Therefore,
more severe cases were referred to our center.
In this study, dominancy of the female gender and left eye
involvement were in accordance with prior studies.11,12 In
some studies, a higher incidence of amblyopia was reported in
bilateral Duane syndrome, probably as a result of more
prevalence of anisometropia, vertical strabismus, and ame-
tropia in bilateral cases, in contrast to the study of Zanin et al
with a similar frequency in unilateral and bilateral cases.13,14
While in our series 2 patients with bilateral involvement had
amblyopia, we could not make any judgment about it because
of the limited number of patients.
The treatment in this syndrome concentrates on the
improvement of primary deviation and abnormal head posture,
not on creating normal adduction or abduction.15 A technique
other than muscle surgery, like botulinum toxin injection,
could be utilized to obtain the treatment's object.16,17 In this
procedure, there is a low possibility of surgical complications
such as scleral perforation, postoperative conjunctival injec-
tion, granuloma and allergic reactions, scar and inclusion cyst
of conjunctiva, adherence syndrome, change in palpebral
fissure, dellen ulcer, and anterior segment ischemia.18 The rate
of complication after botulinum toxin injection is less com-
mon than surgery. Transient complications in our series such
as ptosis, subconjunctival hemorrhage, and vertical deviation
were also reported in prior studies.4,16 In spite of these tran-
sient complications, the permanent effect of botulinum could
be obtained by repeated injections (2e3 times)16 without
creating any permanent degenerative or atrophy of muscle.19
Consequently, botulinum injection could be accepted as a
quite safe treatment.Please cite this article in press as: Ameri A, et al., Botulinum toxin injection in t
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spectrum of strabismus disorders, including congenital eso-
tropia, acute paralytic strabismus, thyroid associated orbitop-
athy, and congenital nystagmus,20e25 there is limited
investigation in the clinical outcome of botulinum toxin in-
jection in the patients with Duane syndrome.4,7 The study of
Dawson et al4 is the chief investigation of efficacy of botuli-
num toxin injection in the treatment of Duane syndrome with
88 cases. They reported 53% reduction of deviation in the long
term. Our results, with 75% improvement (complete or partial)
after botulinum toxin injection, were comparable to the results
of the Merino et al26 study with a 70.58% success rate after
muscle recession in 17 patients. Thus, despite the temporary
effect of botulinum toxin injection, it could be accepted as an
alternative to surgery with fewer complications and a perma-
nent effect with repeated injection.
One of the interesting results in this investigation was the
significant relation between the success rate and amount of
FDT. Better responses were observed in the presence of 1 or
2 þ FDT. Therefore, successful results of botulinum toxin
injection in Duane syndrome could be seen in mild to mod-
erate fibrotic muscles. As a result, FDT could be a predictive
factor for response to botulinum toxin.
The limitations of our study included a small number of the
patients, lack of control group with muscle recession surgery,
absence of special technique for injection in fibrotic muscles,
and lack of long-term follow-up. Other drawbacks of this
investigation were the lack of assessment of up- or downshoot
and globe retraction. Due to the low age of most patients in our
series, evaluation of the outcome of botulinum toxin injection
on stereopsis was not possible.
In conclusion, neither complete improvement, nor lack of
surgical requirement could be gained in patients with Duane
syndrome with botulinum toxin injection. However, botulinum
toxin could be accepted in Duane syndrome instead or asso-
ciated with muscle recession with appropriate case selection. It
may be concluded that patients with lower degrees of FDT had
better response to botulinum toxin injection.
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